Experimental Hematology & Oncology
Experimental Hematology & Oncology(英文缩写 EXP HEMATOL ONCOL),ISSN 2162-3619,eISSN 2162-3619 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。
指标来源：jcr_cas_ifqb
期刊简介
暂无简介。
Experimental Hematology & Oncology 最新收录文献
※ 中文译文由 AI 辅助生成,仅供学术参考,请以英文原文为准。
-
Comparison of haploidentical, matched sibling and matched unrelated donor allo-HCT in adult patients with AML in complete remission with measurable residual disease: a study from the Global committee and the ALWP of the EBMT.
-
Combination of PARPi and topoisomerase I inhibitors is highly effective in olaparib-resistant ovarian cancer.
High-grade serous ovarian carcinoma (HGSOC) often shows an initial response to poly (ADP-ribose) polymerase inhibitors (PARPi) such as olaparib, particularly in tumors with defects in homologous recom…
-
Dysregulated KMT2D mutant targeting immunogenic rewiring to overcome epigenetic entropy promotes follicular lymphomagenesis.
Epigenetic modifier factors in B cell lymphomas often harbor loss-of-function mutations. Mutations occurring in the histone-lysine methyltransferase 2D (KMT2D) gene are the pivotal chromatin-modifying…
-
Multimodal AI and single-cell transcriptomics integrate to construct a histopathological prognostic model for bladder cancer, revealing the RTN3-glycolysis axis in chemoresistance.
Bladder cancer is a common malignant tumor of the urinary system, and gemcitabine-based chemotherapy often fails because of drug resistance. Tumor heterogeneity, particularly copy number variations (C…
-
CD84 expression stratifies venetoclax response and reveals a targetable vulnerability in resistant acute myeloid leukemia.
Venetoclax-based regimens have become increasingly integrated into the therapeutic landscape of acute myeloid leukemia (AML), yet primary resistance and relapses remain major barriers to durable benef…
-
{"_":"Tumor-intrinsic NSUN2 orchestrates immunosuppression in lung adenocarcinoma via the mC-HDAC8-CCL5 axis.","sup":["5"]}
Insufficient T-cell infiltration is a major barrier to the efficacy of immune checkpoint inhibitors (ICIs) in lung adenocarcinoma (LUAD). We aimed to investigate how the tumor-intrinsic mC methyltrans…
-
Chimeric antigen receptor (CAR)-T cell therapy for solid tumors in pediatric patients: current breakthroughs, dilemmas, and strategies.
Chimeric antigen receptor (CAR)-T cell therapy has demonstrated substantial clinical efficacy in pediatric hematologic malignancies; however, its application in pediatric solid tumors remains investig…
-
{"_":"Spatial multi omic profiling maps hypoxia-driven pro-fibrotic SPP1 macrophages underpinning immune escape and TACE resistance in hepatocellular carcinoma.","sup":["+"]} 空间多组学分析揭示了缺氧驱动的促纤维化SPP1巨噬细胞是肝细胞癌免疫逃逸和TACE耐药的基础
To elucidate the cellular and molecular mechanisms underlying therapeutic resistance (refractoriness) following transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC) by comprehensiv…
-
Novel agents and evolving strategies in Waldenström macroglobulinemia: clinical trial updates from ASH 2025.
Waldenström macroglobulinemia (WM) is a rare, indolent lymphoplasmacytic lymphoma characterized by bone marrow infiltration of IgM-secreting lymphoplasmacytic cells and associated with the MYD88(L265P…
-
Unraveling the role of glutamine metabolism in cancer: from cell death mechanisms to tumor microenvironment modulation.
Glutamine, the most abundant amino acid in human serum, serves not only as a key nutrient for maintaining normal cellular biological functions but also as an essential metabolic substrate for the prol…